ArticleFood & nutrition research2026
Dietary magnesium intake modified association between visceral adiposity index and chronic kidney disease: a cross-sectional study.
Article in Food & nutrition research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) is considered as one of the major global public health concerns. The visceral adiposity index (VAI), a marker of visceral fat dysfunction, has been associated with CKD in previous reports; however, evidence from U.S. populations remains limited. In addition, the potential modifying role of dietary magnesium intake in this association is not well understood. This study aimed to investigate the relationship between VAI and CKD among U.S. adults and to explore whether dietary magnesium intake modifies this association. Methods: A total of 2,616 participants from the National Health and Nutrition Examination Survey (NHANES) between 2003 and 2018 were included in this retrospective study. The association between VAI and CKD was evaluated using curve-fitting analyses, multivariable logistic regression models, and subgroup analyses stratified by dietary magnesium intake. Results: A significant positive relation between VAI and CKD was observed only among individuals with low dietary magnesium intake. In this group, each one-unit increase in VAI was associated with higher odds of CKD (odds ratio [OR] = 1.13, 95% confidence interval [CI]: 1.07-1.18; Conclusions: Higher VAI is significantly associated with an increased risk of CKD among U.S. adults with low dietary magnesium intake. Adequate magnesium consumption may attenuate the adverse association between visceral adiposity and kidney health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.